Neuroprotective role of sphingosine-1-phosphate in L-BMAA treated neuroblastoma cells (SH-SY5Y)

Neuroscience Letters

Volumn 593, Issue , 2015, Pages 83-89

  Muñoz Sáez, Emma ^a   de Munck García, Estefanía ^a   Arahuetes Portero, Rosa María ^a   Vicente, Francisca ^b   Ortiz López, Francisco Javier ^b   Cantizani, Juan ^b   Miguel, Begoña Gómez ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Fundación MEDINA Centro de Excelencia en Investigaciovn de Medicamentos Innovadores en Andalucía   (Spain)

Author keywords

GSK3; Neuroprotection; SH SY5Y; Sphingosine 1 phosphate; N methylamine l alanine

Indexed keywords

2 AMINO 3 (METHYLAMINO) PROPIONIC ACID; GLYCOGEN SYNTHASE KINASE 3; PROPIONIC ACID DERIVATIVE; PROTEIN KINASE B; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG; WORTMANNIN; BETA-N-METHYLAMINO-L-ALANINE; DIAMINO ACID; LYSOPHOSPHOLIPID; NEUROPROTECTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN ISOLATION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMINO ACIDS, DIAMINO; APOPTOSIS; CELL LINE, TUMOR; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LYSOPHOSPHOLIPIDS; NECROSIS; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84925278388     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.03.010     Document Type: Article

References (50)

1. Pyne S., Pyne N.J. Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J. 2000, 349:385-402. (Pt 2).
2. Morita Y., Perez G.I., Paris F., Miranda S.R., Ehleiter D., Haimovitz-Friedman A., Fuks Z., Xie Z., Reed J.C., Schuchman E.H., Kolesnick R.N., Tilly J.L. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med. 2000, 6(10):1109-1114.
3. Hancke K., Strauch O., Kissel C., Göbel H., Schäfer W., Denschlag D. Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in vivo. Fertil. Steril. 2007, 87(1):172-177.
4. Bonnaud S., Niaudet C., Legoux F., Corre I., Delpon G., Saulquin X., Fuks Z., Gaugler M.H., Kolesnick R., Paris F. Sphingosine-1-phosphate activates the AKT pathway to protect small intestines from radiation-induced endothelial apoptosis. Cancer Res. 2010, 70(23):9905-9915.
5. Gomez-Brouchet A., Pchejetski D., Brizuela L., Garcia V., Altié M.F., Maddelein M.L., Delisle M.B., Cuvillier O. Critical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-beta peptide. Mol. Pharmacol. 2007, 72(2):341-349.
6. Lee J.H., Jang S., Jeong H.S., Park J.S. Effects of sphingosine-1-phosphate on neural differentiation and neurite outgrowth in neuroblastoma cells. Chonnam Med. J. 2011, 47(1):27-30.
7. Takuwa Y., Du W., Qi X., Okamoto Y., Takuwa N., Yoshioka K. Roles of sphingosine-1-phosphate signaling in angiogenesis. World J. Biol. Chem. 2010, 1(10):298-306.
8. Agudo-López A., Miguel B.G., Fernández I., Martínez A.M. Involvement of mitochondria on neuroprotective effect of sphingosine-1-phosphate in cell death in an in vitro model of brain ischemia. Neurosci. Lett. 2010, 470(2):130-133.
9. Papapetropoulos S. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-l-alanine (BMAA) paradigm. Neurochem. Int. 2007, 50(7-8):998-1003.
10. Brand L.E., Pablo J., Compton A., Hammerschlag N., Mash D.C. Cyanobacterial blooms and the occurrence of the neurotoxin beta-N-methylamino-l-alanine (BMAA) in South Florida aquatic food webs. Harmful Algae 2010, 9(6):620-635.
11. Nunn P.B., Seelig M., Zagoren J.C., Spencer P.S. Stereospecific acute neuronotoxicity of 'uncommon' plant amino acids linked to human motor-system diseases. Brain Res. 1987, 410(2):375-379.
12. Dawson R., Marschall E.G., Chan K.C., Millard W.J., Eppler B., Patterson T.A. Neurochemical and neurobehavioral effects of neonatal administration of beta-N-methylamino-l-alanine and 3,3'-iminodipropionitrile. Neurotoxicol. Teratol. 1998, 20(2):181-192.
13. de Munck E., Muñoz-Sáez E., Miguel B.G., Solas M.T., Ojeda I., Martínez A., Gil C., Arahuetes R.M. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS. Environ. Toxicol. Pharmacol. 2013, 36(2):243-255.
14. 13C NMR. J. Biol. Chem. 1990, 265(18):10193-10195.
15. Bienfang P.K., Defelice S.V., Laws E.A., Brand L.E., Bidigare R.R., Christensen S., Trapido-Rosenthal H., Hemscheidt T.K., McGillicuddy D.J., Anderson D.M., Solo-Gabriele H.M., Boehm A.B., Backer L.C. Prominent human health impacts from several marine microbes: history, ecology, and public health implications. Int. J. Microbiol. 2011, 2011:152815.
16. Embi N. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 1980, 107(2):519-527.
17. Woodgett J.R., Cohen P. Multisite phosphorylation of glycogen synthase: Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5). Biochim. Biophys. Acta 1984, 788:339-347.
18. Cole A.R. GSK3 as a sensor determining cell fate in the brain. Front. Mol. Neurosci. 2012, 5:4.
19. Valvezan A.J., Klein P.S. GSK-3 and Wnt signaling in neurogenesis and bipolar disorder. Front. Mol. Neurosci. 2012, 5:1.
20. Salcedo-Tello P., Ortiz-Matamoros A., Arias C. GSK3 function in the brain during development, neuronal plasticity, and neurodegeneration. J. Alzheimers Dis. 2011, 2011:189728.
21. Liu C.M., Hur E.M., Zhou F.Q. Coordinating gene expression and axon assembly to control axon growth: potential role of GSK3 signaling. Front. Mol. Neurosci. 2012, 5:3.
22. Beurel E., Jope R.S. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog. Neurobiol. 2006, 79(4):173-189.
23. Woodgett J.R. Molecular cloning and expression of glycogen synthase kinase-3: factor A. EMBO J. 1990, 9:2431-2438.
24. Leroy K., Brion J.P. Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J. Chem. Neuroanat. 1999, 16(4):279-293.
25. Xie H.R., Hu L.S., Li G.Y. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin. Med. J. (Engl.) 2010, 123(8):1086-1092.
26. Weiss J.H., Choi D.W. Beta-N-methylamino-l-alanine neurotoxicity: requirement for bicarbonate as a cofactor. Science 1988, 241(4868):973-975.
27. Lee M., McGeer P.L. Weak BMAA toxicity compares with that of the dietary supplement β-alanine. Neurobiol. Aging 2012, 33(7):1440-1447.
28. Okle O., Stemmer K., Deschl U., Dietrich D.R. L-BMAA induced ER stress and enhanced caspase 12 cleavage in human neuroblastoma SH-SY5Y cells at low nonexcitotoxic concentrations. Toxicol. Sci. 2013, 131(1):217-224.
29. Muñoz-Saez E., de Munck E., Arahuetes R.M., Solas M.T., Martínez A.M., Miguel B.G. β-N-methylamino-l-alanine induces changes in both GSK3 and TDP-43 in human neuroblastoma. J. Toxicol. Sci. 2013, 38(3):425-430.
30. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculturetetrazolium assay. Cancer Res. 1988, 48:589-601.
31. 2+ in rat synaptosomes. Acta Neurobiol. Exp. (Wars) 2001, 61(2):113-117.
32. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
33. Dunlop R.A., Cox P.A., Banack S.A., Rodgers K.J. The non-protein amino acid BMAA is misincorporated into human proteins in place of L-serine causing protein misfolding and aggregation. PLoS One 2013, 5376.
34. Chiu A.S., Gehringer M.M., Braidy N., Guillemin G.J., Welch J.H., Neilan B.A. Excitotoxic potential of the cyanotoxin β-methyl-amino-l-alanine (BMAA) in primary human neurons. Toxicon 2012, 60(6):1159-1165.
35. Jantas D., Pytel M., Mozrzymas J.W., Leskiewicz M., Regulska M., Antkiewicz-Michaluk L., Lason W. The attenuating effect of memantine on staurosporine- salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem. Int. 2008, 52:864-877.
36. Ross S.M., Seelig M., Spencer P.S. Specific antagonism of excitotoxic action of 'uncommon' amino acids assayed in organotypic mouse cortical cultures. Brain Res. 1987, 425(1):120-127.
37. Vance J.M., Ali S., Bradley W.G., Singer C., Di Monte D. Gene environment interactions in Parkinsońs disease and other forms of parkinsonism. Neurotoxicology 2010, 31:598-602.
38. Tavarini S., Colombaioni L., Garcia-Gil M. Sphingomyelinase metabolites control survival and apoptotic death in SH-SY5Y neuroblastoma cells. Neurosci. Lett. 2000, 285(3):185-188.
39. Miguel B.G., Fernández I., Toboso I., Agudo-López A., Catalán E., Martínez A.M. Sphingosylphosphorylcholine induces mitochondria-mediated apoptosis in neuro 2a cells: involvement of protein kinase C. Acta Neurobiol Exp (Wars) 2008, 68(4):443-452.
40. Holtcamp W. The enmerging science of BMAA: do cyanobactera contribute to neurodegenerative disease. Environ. Health Perspect. 2012, 120:A110-A116.
41. Van Brocklyn J.R., Williams J.B. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2012, 163(1):26-36.
42. Meng H., Yuan Y., Lee V.M. Loss of sphingosine kinase 1/S1P signaling impairs cell growth and survival of neurons and progenitor cells in the developing sensory ganglia. PLoS One 2011, 6(11):e27150.
43. Jope R.S., Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 2004, 29(2):95-102.
44. Chung Y.H., Joo K.M., Kim D.J., Kim S.S., Kim K.Y., Lee W.B., Cha C.I. Immunohistochemical study on the distribution of glycogen synthase kinase 3alpha in the central nervous system of SOD1(G93A) transgenic mice. Neurol. Res. 2008, 30(9):926-931.
45. Azoulay-Alfaguter I., Yaffe Y., Licht-Murava A., Urbanska M., Jaworski J., Pietrokovski S., Hirschberg K., Eldar-Finkelman H. Distinct molecular regulation of glycogen synthase kinase-3alpha isozyme controlled by its Nterminal region: functional role in calcium/calpain signaling. J. Biol. Chem. 2011, 286(15):13470-13480.
46. Meares G.P., Jope R.S. Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis. J. Biol. Chem. 2007, 282(23):16989-17001.
47. Bijur G.N., Jope R.S. Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta. J. Biol. Chem. 2001, 276(40):37436-37442.
48. + deprivation in cerebellar granule cells. J. Neurochem. 2001, 78(1):199-206.
49. Nakahara T., Iwase A., Nakamura T., Kondo M., Bayasula Kobayashi H., Takikawa S., Manabe S., Goto M., Kotani T., Kikkawa F. Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. Fertil. Steril. 2012, 98(4):1001-1008.
50. Hasegawa Y., Suzuki H., Sozen T., Rolland W., Zhang J.H. Activation of sphingosine-1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 2010, 41(2):368-374.